JPRN-UMIN000041621尚未招募未知
Pooled safety and efficacy analysis of trifluridine/tipiracil plus bevacizumab in five clinical trials using individual data from patients with metastatic colorectal cancer - Pooled safety and efficacy analysis of trifluridine/tipiracil plus bevacizumab in five clinical trials using individual data from patients with metastatic colorectal cancer
The 22nd Century Cutting-Edge Medical Informaion Technology Organization0 个研究点目标入组 239 人开始时间: 2020年9月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 239
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Nothing in particular
研究者
相似试验
进行中（未招募）
不适用
Real-world Effectiveness and Safety of Trifluridine/Tipiracil plus bevacizumab in Metastatic Colorectal Cancer: A retrospective observational study using an administrative databaseColorectal cancerJPRN-jRCT1031220116Taiho Pharmaceutical Co., Ltd. Medical Affairs Division11,962
已完成
4 期
A clinical trial to study the effect of Triflusal in Aspirin resitant patientsCTRI/2011/04/001679Glenmark Pharmaceuticals Lts40
进行中（未招募）
1 期
Efficacy and safety of Trifluridine/Tipiracil in combination with Irinotecan as a secondline therapy in patients with bile duct cancerPatients with advanced, non resectable or metastatic cholangio- and gallbladder carcinoma after failure to respond to a previous gemcitabine treatment.EUCTR2018-002936-26-DEHeinrich-Heine-University Düsseldorf28
尚未招募
Unknown
A retrospective observational study of trifluridine tipiracil plus minus bevacizumab in pretreated mCRC patients with MSI-H MMR-D metastatic colorectal cancerJPRN-UMIN000051378The 22nd Century Cutting-Edge Medical Informaion Technology Organization15
招募中
2 期
Oxaliplatin ± nivolumab in combination with trifluridine/tipiracil or 5- fluorouracile ± nivolumab in frail patients with advanced, recurrent or metastatic gastric, oesophageal or gastroesophageal junction cancer2024-512999-35-00Unicancer118